Get the Stockscreener App
25.01
2.67%
0.65
After Hours:
25.49
0.48
+1.92%
Overview
News
Price History
Option Chain
Why RGS Down?
Discussions
Forecast
Stock Split
Dividend History
Regis Corp. Stock (RGS) Latest News
Regis hit by charges for beauty school merger - CosmeticsDesign-Europe.com
Regis Corporation (NYSE:RGS) Q1 2025 Earnings Call Transcript - Insider Monkey
Regis Corp (RGS) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives By GuruFocus - Investing.com Canada
Regis: Fiscal Q1 Earnings Snapshot - Houston Chronicle
Regis Corporation Reports Continued Profitability for the First Fiscal Quarter 2025 - Yahoo Finance
Regis Corp Reports Q1 2025 Earnings: Adjusted EPS at $0.93, Reve - GuruFocus.com
Regis to Issue First Quarter Fiscal 2025 Results on November 6, 2024 - Yahoo Finance
Supercuts® Debuts Nationwide Loyalty Program with Guests Able to Earn Free Haircuts and More - Quantisnow
Lapses in autopsy report: RG Kar doctor at CBI office for interrogation - Lokmat Times
RG Kar case: CBI finds more procedural lapses in autopsy report - Lokmat Times
Keros Therapeutics Inc [KROS] Insider GORDON CARL L sells 250,000 Shares for $250,000 - Knox Daily
Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily
Regeneron slump continues as analysts turn more cautious - MSN
Keros Therapeutics Inc (KROS)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
GRI’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Closing Strong: Mereo Biopharma Group Plc ADR (MREO) Ends at 4.09, Down -3.76 from Last Close - The Dwinnex
GEELY AUTO Partners with Tasco to Set Up Auto Assembly Plant in Vietnam w/ Total Investment Amt ~US$168M - AASTOCKS.com
Cong asks Guv to intervene in “illegally IPB permitted” mega projects in Reis Magos - Herald Goa
Keros Therapeutics (NASDAQ:KROS) Shares Gap Up to $55.80 - MarketBeat
How the (KROS) price action is used to our Advantage - Stock Traders Daily
How does Keros Therapeutics Inc (KROS) change from a tortoise to a hare? - SETE News
Keros Therapeutics (NASDAQ:KROS) Receives New Coverage from Analysts at Guggenheim - MarketBeat
Guggenheim starts Keros Therapeutics with 'buy' on lung disorder drug potential - XM
Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects - Investing.com Australia
Regis drops $103.5m on aged care villages - realestatesource.com.au
Public Employees Retirement Association of Colorado Sells 674 Shares of Targa Resources Corp. (NYSE:TRGP) - Defense World
Latest News LIVE Updates: RG Kar junior doctors withdraw 42-day `cease work` - mid-day.com
Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Up to $3.95 - Defense World
RG Kar scam: CBI gets clues of Sandip Ghosh illegally awarding contracts to biz entity - Punjab News Express
Regis Healthcare (ASX:REG) share price jumps on acquisition, aged care reforms - Rask Media
Australia's Regis Healthcare hits over 8-yr high as co plans to acquire residential homes - XM
Up 124% in a year, ASX 300 healthcare share lifts off on $35 million acquisition - MSN
Edgestream Partners L.P. Makes New Investment in Herc Holdings Inc. (NYSE:HRI) - Defense World
Mereo BioPharma Group plc (NASDAQ:MREO) Insider Sells $23,297.64 in Stock - Defense World
Odisha: Government introduces new safety policy for medical professionals Post RG Kar rape incident - Organiser
R G Kar case: ED summons TMC MLA Sudipto Roy for questioning - NewsDrum
ED seizes documents from TMC MLA’s home in RG Kar Hospital bungling case - Medical Buyer
RG Kar case: CPI(M) youth leader Minakshi Mukherjee appears before CBI - The Economic Times
Mereo BioPharmaLazarus-Like Recovery Impresses, But Lack Of Clarity On Potential Approval Timelines - Seeking Alpha
After RG Kar Episode In Kolkata, Odisha Govt Issues Guidelines For Doctors’ Safety - OdishaBytes
Mereo Biopharma Group Plc ADR (MREO) stock: A year of ups and downs - US Post News
Mereo Biopharma Group Plc ADR (MREO) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Mereo BioPharma Group plc (MREO): A Bull Case Theory - Insider Monkey
'Next decade is likely to be a golden era' for ASX shares in this sector - The Motley Fool Australia
BMO holds stock target, outperform rating on Regeneron shares - Investing.com India
Mereo BioPharma Group plc (NASDAQ:MREO) CEO Denise Scots-Knight Sells 28,611 Shares - Defense World
Mereo BioPharma Group plc (NASDAQ:MREO) CFO Christine Ann Fox Sells 9,128 Shares of Stock - Defense World
Mereo BioPharma CFO sells over $121k in company stock - Investing.com
Mereo BioPharma's chief scientific officer sells shares worth over $69,000 - Investing.com India
Mereo BioPharma CFO sells over $120k in company stock - Investing.com India
Mereo BioPharma's general counsel sells over $133k in company stock - Investing.com UK
Views of Wall Street’s Leading Experts on Mereo Biopharma Group Plc ADR - SETE News
Bulk Deals: Societe Generale buys 6.1 lakh shares in Kross Limited - Moneycontrol
Monitoring Mereo Biopharma Group Plc ADR (MREO) after recent insider movements - Knox Daily
Regis: Focus On Turnaround Not Metrics (NASDAQ:RGS) - Seeking Alpha
Market Watch Highlights: Regis Corp. (RGS) Ends on an Downturn Note at 21.00 - The Dwinnex
Regis Corporation (NYSE:RGS) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Regis Corporation reports growth and strategic refinancing - Investing.com
Regis: Fiscal Q4 Earnings Snapshot - mySA
Regis Corporation Reports Continued Profitability for the Fourth Fiscal Quarter and Full Fiscal Year 2024 - Yahoo Finance
Bottom 100 Stocks to Buy: Is Regis Corp. Uninvestable? - Nasdaq
2.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):